Device ([18F]-FDG PET-CT, X1 RMRS PET-CT) for Blood Cancers

City of Hope Medical Center, Duarte, CA
Blood Cancers+1 More ConditionsComputed Tomography - Procedure
Eligibility
18+
All Sexes

Study Summary

This trial compares PET-CT imaging using [18F]-FDG to RefleXion Medical Radiotherapy System (RMRS) imaging to potentially improve radiation therapy targeting of cancer cells.

Eligible Conditions
  • Blood Cancer
  • Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Fluorine F 18 Fluorthanatrace
1
Sunscreen
1
Device Arm

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Up to 72 hours

Up to 72 hours
Imaging performance of X1 RefleXion Medical Radiotherapy System (RMRS) positron emission tomography (PET)-computed tomography (CT) with the Imaging performance of the diagnostic fludeoxyglucose F-18 ([18F]-FDG) PET-CT
Percent of cases where X1 RMRS PET data can be used to generate an acceptable biology-guided radiotherapy (BgRT) plan

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Fluorine F 18 Fluorthanatrace
1
Sunscreen
1
Device Arm

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Device ([18F]-FDG PET-CT, X1 RMRS PET-CT)
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Device ([18F]-FDG PET-CT, X1 RMRS PET-CT) · No Placebo Group · N/A

Device ([18F]-FDG PET-CT, X1 RMRS PET-CT)Experimental Group · 4 Interventions: Computed Tomography, Medical Device Usage and Evaluation, Fludeoxyglucose F-18, Positron Emission Tomography · Intervention Types: Procedure, Other, Other, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Computed Tomography
2017
Completed Phase 2
~2710
Positron Emission Tomography
2008
Completed Phase 2
~2290

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 72 hours

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
535 Previous Clinical Trials
2,249,934 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,281 Previous Clinical Trials
41,235,106 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Jeffrey Y WongPrincipal InvestigatorCity of Hope Medical Center
6 Previous Clinical Trials
161 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Is there currently an opportunity to join this experiment?

"The latest update on clinicaltrials.gov implies that this medical research is now welcoming applicants. This was first advertised on March 15th, 2023 and the most recent changes were made to the listing in May 3rd of the same year." - Anonymous Online Contributor

Unverified Answer

How many participants are participating in this scientific experiment?

"Affirmative. According to the information on clinicaltrials.gov, this research project is actively enrolling participants at 1 location and a total of 20 individuals are required for completion. The trial was initially published on March 15th 2023 with its last update occurring on May 3rd2023." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top